If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
550.00    0.00 (0.00%)
Bid:
540.00
Ask:
560.00
Spread: 20.00 (3.704%)
Market Cap: £90.06m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Acquisition

3 Feb 2017 07:00

RNS Number : 9221V
Anpario PLC
03 February 2017
 

 

 

 

 

 

Anpario plc

("Anpario" or "the Company")

ANPARIO PLC ACQUIRES AUSTRALIAN DISTRIBUTOR - COBBETT PTY

 

Anpario plc, the international producer and distributor of natural feed additives for animal health, hygiene and nutrition is pleased to announce the acquisition of the business and assets of Cobbett Pty Ltd. Cobbett has been Anpario's distributor since 1987 supplying Australia, New Zealand and Papua New Guinea with a number of Anpario's key product brands including: Salkil, pHorce, Neutox, Mycostat and Mastercube.

In the year to 30 June 2016 Cobbett had sales of A$1.76m. The initial consideration is for A$700,000 plus stock as valued plus a further A$300,000 should the business achieve certain profit targets over a 12 month earnout period. A significant proportion of Cobbett's business is with the Anpario product range, which drove the logic for the acquisition. However, Cobbett also distributes other complementary products which it will continue to do so and we look forward to continuing these supplier relationships.

The acquisition of Cobbett is very much in line with our strategy to strengthen our sales and distribution channels and develop closer relationships with end users of our products. Anpario strives to respond and make decisions quickly to ensure our customers receive the best technical support and service possible. Acquiring Cobbett helps us to better deliver a responsive and proactive customer care ethos.

The Anpario team is looking forward to working with the Cobbett team and its customers and suppliers in the region.

Further to the acquisition, Anpario would also like to take this opportunity to highlight its recent rebranding exercise as part of a process to phase out the individual trading brands. Consolidating into a single brand will enable Anpario to communicate more effectively in terms of our corporate vision, philosophy and values as well as concentrating more marketing and R&D spend behind one brand rather than three. In line with this process, Anpario have launched a new Global website that can be found at www.anpario.com.

 

Anpario plc

Richard Edwards Chief Executive Officer +44(0) 777 6417 129Karen Prior Finance Director +44(0) 190 9537 380

 

Peel Hunt LLP +44(0) 207 4188 900Adrian Trimmings

George Sellar

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQOKBDPABKDNBK
Date   Source Headline
16th Dec 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
16th Dec 20247:00 amRNSLaunch of SAYE Scheme
29th Nov 20247:00 amRNSTotal Voting Rights
30th Sep 20247:00 amRNSAcquisition of Bio-Vet Inc.
13th Sep 20247:00 amRNSNotice of Investor Presentation
11th Sep 20247:00 amRNSInterim results
14th Aug 202411:22 amRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSBlock listing Interim Review
25th Jun 20242:34 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Statement
12th Jun 20244:11 pmRNSHolding(s) in Company
24th May 202410:04 amRNSPosting of Annual Report and Notice of AGM
21st Mar 202411:37 amRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAward of Options and Director/PDMR Shareholding
24th Jan 20247:00 amRNSFull year trading statement
17th Jan 20247:00 amRNSBlock listing Interim Review
5th Oct 20239:23 amRNSDirector Disclosure
13th Sep 20237:00 amRNSHalf-year Report
25th Aug 20235:10 pmRNSBlock listing Interim Review
1st Aug 20237:00 amRNSDirectorate Change
10th Jul 20232:14 pmRNSHolding(s) in Company
7th Jul 20232:34 pmRNSHolding(s) in Company
29th Jun 20233:57 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
23rd Jun 20237:00 amRNSResult of Tender Offer
19th Jun 20232:48 pmRNSGM Statement
15th Jun 20237:00 amRNSShareholder Tour
7th Jun 20234:09 pmRNSReplacement - Tender Offer
6th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20237:00 amRNSTender Offer
23rd May 20237:00 amRNSChange of Adviser
19th May 20234:40 pmRNSDirector Disclosures
19th May 20233:35 pmRNSTotal Voting Rights
5th May 20237:00 amRNSDirectorate Change
21st Apr 20237:00 amRNSAnpario receives King’s Award for Enterprise
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20231:13 pmRNSHolding(s) in Company
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSFinal Results
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
24th Jan 202312:56 pmRNSBlock listing Interim Review
9th Jan 20237:00 amRNSFull Year Trading Statement
16th Dec 20227:00 amRNSAnpario receives ISO 14001 Certification
4th Nov 202212:52 pmRNSTotal Voting Rights
19th Oct 20227:00 amRNSDirector/PDMR Shareholding - Replacement
18th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSESG Initiatives
3rd Oct 20222:32 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.